Industry Commitment For Antibiotic Resistance Strategy

by | Apr 8, 2014 | News | 0 comments

In an update to the public last week, the FDA announced that all but one animal drug company have committed to seek withdrawal of approvals for any production uses of affected drug applications and change the remaining therapeutic uses of their products from over-the-counter to use by Veterinary Feed Directive or prescription. These changes stem from the implementation of FDA Guidance #213 that was announced in December of last year. The FDA is pleased with the strong responses received thus far and promises to continue to provide updates to the public. For the official announcement from the FDA, read here.

Recent GVL Blog Posts

Digital Rabies Certificates Launch Soon

Digital Rabies Certificates Launch Soon

No more wasted time on rabies certificatesSoon, GVL users will be able to save time and streamline workflows with digital rabies certificates - FREE for a limited time. "With the upcoming launch of GVL's international pet movement solution, we've developed a digital...

Upcoming Events and Shows

Upcoming Events and Shows

The GVL team is looking forward to the events and shows coming up this month. We hope to see you there. NCBA Convention Attending OnlyFebruary 5-7, 2020 San Antonio, TX Learn more: convention.ncba.org/ Western Veterinary Conference (WVC) Booth 1307February 16-19,...

GVL Regulatory Expert David Schmitt, DVM

GVL Regulatory Expert David Schmitt, DVM

The GVL® Expert Council was created to better understand our customers’ needs by providing industry knowledge and expertise for product development. We are featuring our Expert Council members on our blog so you can learn more about their fields of research and the...